New standard, released on Monday, is the country’s only existing detailed set of recommendations for treating and minimizing pain in pediatric patients
We sure need a new pain medicine without the baggage of NSAIDs or the stigma of opioids. Johnson & Johnson thinks it might have an answer - a derivative of Tylenol without the associated liver toxicity. But does it treat pain? Not very well.